PNV 1.86% $2.19 polynovo limited

I have struggled to understand how it is that the market utterly...

  1. 5,259 Posts.
    lightbulb Created with Sketch. 241
    I have struggled to understand how it is that the market utterly fails to value this company fairly considering the future near and middle term prospects and I can only come to one conclusion.

    Without substantial further applications of the NovoSorb platform beyond BTM making real R&D progress, then inevitably the market will increasingly see the company as less a paradigm breaking, market making innovator and more and more a bulk biodegradable foam purveyor. It’s all good that BTM and its derivative products are succeeding but I fear that’s not enough to let us see blue sky again. We need real movement on other applications in orthopedics, breast reconstruction, maybe bone fixation, maybe surgical wound closing, something - anything - with prospects beyond BTM.
    Last edited by jevalent: 05/09/23
 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
(20min delay)
Last
$2.19
Change
0.040(1.86%)
Mkt cap ! $1.504B
Open High Low Value Volume
$2.15 $2.20 $2.14 $1.788M 826.3K

Buyers (Bids)

No. Vol. Price($)
17 18666 $2.18
 

Sellers (Offers)

Price($) Vol. No.
$2.19 35643 29
View Market Depth
Last trade - 14.25pm 30/05/2024 (20 minute delay) ?
Last
$2.19
  Change
0.040 ( 1.67 %)
Open High Low Volume
$2.15 $2.20 $2.14 252541
Last updated 14.45pm 30/05/2024 ?
PNV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.